Akèy › Kansè Vezik ki pa envazif miskilè › New York
Etid klinik pou Kansè Vezik ki pa envazif miskilè nan New York
16 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan New York.
Vil nan New York
- New York City10 etid
- Syracuse8 etid
- Greenburgh4 etid
- Queens4 etid
- Staten Island4 etid
- New Rochelle3 etid
- Buffalo3 etid
- The Bronx3 etid
Tèks ofisyèl etid la (Anglè)
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medical Center, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06503614Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Icahn School of Medicine at Mount Sinai (ISMMS) - Mount Sinai Queens - Infusion Center, Astoria
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center - Sidney Kimmel Center for Prostate and Urologic Cancers, New York
- ak 3 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Associated Medical Professionals, Syracuse
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- MSK Commack, Commack
- MSK Westchester, Harrison
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- ak 9 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- SUNY Upstate Med Univ, Syracuse
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07309445A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- Roswell Park Comprehensive Cancer Center, Buffalo
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06733363Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
- University of Rochester, Department of Urology, Rochester
- Associated Medical Professionals of NY, PLLC, Syracuse
- ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- New York University (NYU), New York
- Weill Cornell Medicine, New York
- Icahn School of Medicine at Mount Sinai, New York
- ak 4 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
- Memorial Sloan Kettering Suffolk - Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), East White Plains
- Columbia University (Data Collection Only), New York
- ak 2 plis
Ap rekriteFaz 3
Laj 21 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06929286Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ak 1 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05126472LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Albany Medical College, Albany
- Roswell Park Cancer Institute, Buffalo
- Mount Sinai Medical Center, New Haven
- ak 1 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
- SUNY Upstate Medical University, Syracuse
Ap rekriteFaz 1/2
Laj 18 a 85 · Tout sèks · Mizajou Mar 27, 2026 · NCT06800963Blue Light Cystoscopy With Cysview® Registry
- NYU Langone's Perlmutter Cancer Center, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT02660645Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
- Site 02-015 - Associated Medical Professionals of New York, Syracuse
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Nov 24, 2025 · NCT03945162Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.